HKE HOLDINGS (01726) plans to offer 100 million shares for sale, raising approximately HK$1.19 billion.
HKE Holdings (01726) announced on February 4, 2026 (after trading hours) that the company has entered into a placement agreement with the placing agent, Grand Saint Securities Limited. According to the agreement, the company has conditionally agreed to place up to 100 million shares at a placement price of HK$1.2 per share through the placing agent to no fewer than six placees (who must be independent third parties or persons not acting in concert with any other placee) on a best efforts basis.
HKE HOLDINGS (01726) announced that on February 4, 2026 (after trading hours), the company entered into a placing agreement with Grand Saint Securities Limited, whereby the company conditionally agreed to place up to 100 million new shares at a placing price of HK$1.2 per share to not less than six placees (who must be independent third parties or not acting in concert with any other placee).
The maximum number of placing shares represents approximately 9.28% of the existing issued share capital of the company as of the date of the announcement; and approximately 8.49% of the enlarged issued share capital of the company after the placing (assuming no change in the issued share capital from the date of announcement until completion).
Assuming all 100 million placing shares are fully subscribed, the total proceeds from the placing will be HK$120 million, and the net proceeds will be HK$119 million (after deducting placing commissions and other expenses) (i.e. the net issue price per placing share is HK$1.188).
The company intends to use approximately HK$65 million (about 55% of the net proceeds) to fund its financial technology platform business; approximately HK$30 million (about 25% of the net proceeds) for strategic investment opportunities; and the remaining HK$23.8 million (about 20% of the net proceeds) for general working capital of the group.
Related Articles

CSSC Offshore & Marine Engineering (00317) subsidiary signs contract to build 16 feeder container ships.

Shen Zhen Weiguang Biological Products (002880.SZ) plans to establish a project company to build a market-oriented public service platform for cell and gene therapy in Shenzhen.

Affiliated with Hing Yip Holdings (00132) enters into a financial leasing agreement with Kangquan Sewage Treatment Plant in Qingyun County.
CSSC Offshore & Marine Engineering (00317) subsidiary signs contract to build 16 feeder container ships.

Shen Zhen Weiguang Biological Products (002880.SZ) plans to establish a project company to build a market-oriented public service platform for cell and gene therapy in Shenzhen.

Affiliated with Hing Yip Holdings (00132) enters into a financial leasing agreement with Kangquan Sewage Treatment Plant in Qingyun County.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


